New York City, New York
"Our immediate goal is lower net prices and lower list prices, and our more immediate actions are aimed at using the tools we know are successful—competition, negotiation and pricing incentives—to effect that outcome. Lower prices for drugs will mean, in some cases, slimmer profit margins. For other parts of the drug market, like pharmacy benefit managers, our plans may involve transforming their business model."
No hay comentarios:
Publicar un comentario